You are here
Home > Posts tagged "FDA Removes Partial Clinical Hold For Esperion’s Drug for Bad Cholesterol"

Esperion Therapeutics Cholesterol Drug Issue with FDA

Esperion Therapeutics Cholesterol Drug

Esperion Therapeutics Cholesterol Drug Esperion Therapeutics, Inc. is a public, American pharmaceutical company focused on the development of a first-in-class, orally available, small molecule designed to significantly lower elevated levels of LDL-C - with the reduced potential for muscle-related side effects associated with statin use. Company Overview Esperion is a pharmaceutical company

Top